{"id":38366,"date":"2026-07-17T01:05:00","date_gmt":"2026-07-16T23:05:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=ba1e467d6adf1c06f3e258ac1149f9eb"},"modified":"2026-07-17T01:05:00","modified_gmt":"2026-07-16T23:05:00","slug":"genedx-to-report-second-quarter-2026-financial-results-on-monday-august-3-2026","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=38366","title":{"rendered":"GeneDx to Report Second Quarter 2026 Financial Results on Monday, August 3, 2026"},"content":{"rendered":"

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced it will release financial results for the second quarter of 2026 after the market closes on Monday, August 3, 2026. Management will host a conference call that day to discuss second quarter 2026 financial and operating results at 4:30 p.m. Eastern Time.<\/p><\/a><\/a>

\nConference Call Details<\/p>

\nInvestors interested in listening to the conference call are required to register online. A live and archived webcast of the event will be available on the \u201cEvents\u201d section of the GeneDx investor relations website at https:\/\/ir.genedx.com\/<\/a>.<\/p>

\nAbout GeneDx<\/b><\/p>

\nGeneDx\u2019s (Nasdaq: WGS) mission is to empower everyone to live their healthiest life through genomics. GeneDx combines unmatched clinical expertise, advanced technology, and the power of GeneDx Infinity\u2122 \u2013 the world\u2019s largest rare disease genomic dataset. This unparalleled foundation powers GeneDx\u2019s ExomeDx\u2122 and GenomeDx\u00ae<\/sup> tests \u2013 ranked #1 by expert geneticists and granted FDA Breakthrough Device designation \u2013 enabling clinicians to deliver precise, fast, and actionable diagnoses. GeneDx Infinity\u2122 also fuels discovery for biopharma, with the most powerful AI-driven genomic intelligence. A genomics pioneer over the last 25 years, diagnosing more than 4,800 genetic diseases and publishing more than 1,100 research publications, GeneDx is building the network that will drive the future of genomic precision medicine. For more information, visit genedx.com<\/b><\/a> and connect with us on LinkedIn<\/b><\/a>, Facebook<\/b><\/a>, and Instagram<\/b><\/a>.<\/p> Contacts<\/b>

\nInvestor Relations Contact:<\/b>Investors@GeneDx.com<\/a><\/p>

\nMedia Contact:<\/b>Press@GeneDx.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"

GAITHERSBURG, Md.–(BUSINESS WIRE)–GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced it will release financial results for the second quarter of 2026 after the market clo…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-38366","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/38366","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=38366"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/38366\/revisions"}],"predecessor-version":[{"id":38367,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/38366\/revisions\/38367"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=38366"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=38366"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=38366"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}